The Europe Home Healthcare Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
It's possible for a patient to need urgent treatment, necessitating many daily special operations. The expense of in-hospital treatment is often substantially higher, and it is not practical to keep the patient there for an extended amount of time as it is not cost-effective. In-home care offers patients hospital-quality, specialized medical treatment in the convenience of their own homes. When compared to hospital treatment, it is far less expensive.
Long-term confinement in a hospital setting may be detrimental to someone's mental health. Hospitals are often linked with 'something wrong, ' and because of their surroundings, patients may feel burdened and anxious there. Constantly interacting with medical personnel, nurses, and patients may also be detrimental.
With the assistance of in-home nursing care, the patient may get expert medical attention in a setting that is familiar to them. Being at home in a cozy, caring setting relieves stress and allows the mind to unwind. It is known that a positive outlook and comfortable surroundings aid in a patient's faster and healthier recovery.
In the last several decades, the WHO European Region has seen a significant increase in life expectancy. In many European nations, the percentage of elderly individuals in the overall population is continuously rising, and it is anticipated that this trend will continue in the next decades. In the majority of EU nations, the central government has outlined its policy for home care. This will result in a rise in the number of elderly persons who need care. The home healthcare market is expected to expand in the Europe area over the next years as a result of all these factors.
The Germany market dominated the Europe Home Healthcare Market by Country in 2021; thereby, achieving a market value of $26, 194.4 million by 2028. The UK market is exhibiting a CAGR of 7.1% during (2022-2028). Additionally, The France market would experience a CAGR of 8.9% during (2022-2028).
Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy and Pregnancy Care. Based on Product Type, the market is segmented into Therapeutic Products, Testing, Screening, & Monitoring Products and Mobility Care Products. Based on Indication, the market is segmented into Cancer & Other Indications, Respiratory Diseases, Wound Care, Pregnancy, Movement Disorders, Hearing Disorders, Cardiovascular Diseases & Hypertension and Diabetes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.
It's possible for a patient to need urgent treatment, necessitating many daily special operations. The expense of in-hospital treatment is often substantially higher, and it is not practical to keep the patient there for an extended amount of time as it is not cost-effective. In-home care offers patients hospital-quality, specialized medical treatment in the convenience of their own homes. When compared to hospital treatment, it is far less expensive.
Long-term confinement in a hospital setting may be detrimental to someone's mental health. Hospitals are often linked with 'something wrong, ' and because of their surroundings, patients may feel burdened and anxious there. Constantly interacting with medical personnel, nurses, and patients may also be detrimental.
With the assistance of in-home nursing care, the patient may get expert medical attention in a setting that is familiar to them. Being at home in a cozy, caring setting relieves stress and allows the mind to unwind. It is known that a positive outlook and comfortable surroundings aid in a patient's faster and healthier recovery.
In the last several decades, the WHO European Region has seen a significant increase in life expectancy. In many European nations, the percentage of elderly individuals in the overall population is continuously rising, and it is anticipated that this trend will continue in the next decades. In the majority of EU nations, the central government has outlined its policy for home care. This will result in a rise in the number of elderly persons who need care. The home healthcare market is expected to expand in the Europe area over the next years as a result of all these factors.
The Germany market dominated the Europe Home Healthcare Market by Country in 2021; thereby, achieving a market value of $26, 194.4 million by 2028. The UK market is exhibiting a CAGR of 7.1% during (2022-2028). Additionally, The France market would experience a CAGR of 8.9% during (2022-2028).
Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy and Pregnancy Care. Based on Product Type, the market is segmented into Therapeutic Products, Testing, Screening, & Monitoring Products and Mobility Care Products. Based on Indication, the market is segmented into Cancer & Other Indications, Respiratory Diseases, Wound Care, Pregnancy, Movement Disorders, Hearing Disorders, Cardiovascular Diseases & Hypertension and Diabetes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Type
- Services
- Skilled Nursing
- Rehabilitation Therapy
- Hospice & Palliative Care
- Unskilled Care
- Respiratory Therapy
- Infusion Therapy
- Pregnancy Care
- Product
- Therapeutic Products
- Testing, Screening, & Monitoring Products
- Mobility Care Products
By Indication
- Cancer & Other Indications
- Respiratory Diseases
- Wound Care
- Pregnancy
- Movement Disorders
- Hearing Disorders
- Cardiovascular Diseases & Hypertension
- Diabetes
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Amedisys, Inc.
- LHC Group, Inc.
- ResMed, Inc.
- Omron Corporation
- Abbott Laboratories
- Invacare Corporation
- Linde PLC
- A&D HOLON Holdings Company, Limited
- Fresenius SE & Co. KGaA
- F.Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Home Healthcare Market, by Type
1.4.2 Europe Home Healthcare Market, by Indication
1.4.3 Europe Home Healthcare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Home Healthcare Market
Chapter 4. Europe Home Healthcare Market by Type
4.1 Europe Services Market by Country
4.2 Europe Home Healthcare Market by Services Type
4.2.1 Europe Skilled Nursing Market by Country
4.2.2 Europe Rehabilitation Therapy Market by Country
4.2.3 Europe Hospice & Palliative Care Market by Country
4.2.4 Europe Unskilled Care Market by Country
4.2.5 Europe Respiratory Therapy Market by Country
4.2.6 Europe Infusion Therapy Market by Country
4.2.7 Europe Pregnancy Care Market by Country
4.3 Europe Product Market by Country
4.4 Europe Home Healthcare Market by Product Type
4.4.1 Europe Therapeutic Products Market by Country
4.4.2 Europe Testing, Screening, & Monitoring Products Market by Country
4.4.3 Europe Mobility Care Products Market by Country
Chapter 5. Europe Home Healthcare Market by Indication
5.1 Europe Cancer & Other Indications Market by Country
5.2 Europe Respiratory Diseases Market by Country
5.3 Europe Wound Care Market by Country
5.4 Europe Pregnancy Market by Country
5.5 Europe Movement Disorders Market by Country
5.6 Europe Hearing Disorders Market by Country
5.7 Europe Cardiovascular Diseases & Hypertension Market by Country
5.8 Europe Diabetes Market by Country
Chapter 6. Europe Home Healthcare Market by Country
6.1 Germany Home Healthcare Market
6.1.1 Germany Home Healthcare Market by Type
6.1.1.1 Germany Home Healthcare Market by Services Type
6.1.1.2 Germany Home Healthcare Market by Product Type
6.1.2 Germany Home Healthcare Market by Indication
6.2 UK Home Healthcare Market
6.2.1 UK Home Healthcare Market by Type
6.2.1.1 UK Home Healthcare Market by Services Type
6.2.1.2 UK Home Healthcare Market by Product Type
6.2.2 UK Home Healthcare Market by Indication
6.3 France Home Healthcare Market
6.3.1 France Home Healthcare Market by Type
6.3.1.1 France Home Healthcare Market by Services Type
6.3.1.2 France Home Healthcare Market by Product Type
6.3.2 France Home Healthcare Market by Indication
6.4 Russia Home Healthcare Market
6.4.1 Russia Home Healthcare Market by Type
6.4.1.1 Russia Home Healthcare Market by Services Type
6.4.1.2 Russia Home Healthcare Market by Product Type
6.4.2 Russia Home Healthcare Market by Indication
6.5 Spain Home Healthcare Market
6.5.1 Spain Home Healthcare Market by Type
6.5.1.1 Spain Home Healthcare Market by Services Type
6.5.1.2 Spain Home Healthcare Market by Product Type
6.5.2 Spain Home Healthcare Market by Indication
6.6 Italy Home Healthcare Market
6.6.1 Italy Home Healthcare Market by Type
6.6.1.1 Italy Home Healthcare Market by Services Type
6.6.1.2 Italy Home Healthcare Market by Product Type
6.6.2 Italy Home Healthcare Market by Indication
6.7 Rest of Europe Home Healthcare Market
6.7.1 Rest of Europe Home Healthcare Market by Type
6.7.1.1 Rest of Europe Home Healthcare Market by Services Type
6.7.1.2 Rest of Europe Home Healthcare Market by Product Type
6.7.2 Rest of Europe Home Healthcare Market by Indication
Chapter 7. Company Profiles
7.1 Amedisys, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Acquisition and Mergers:
7.2 LHC Group, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Partnerships, Collaborations, and Agreements:
7.2.4.2 Acquisition and Mergers:
7.3 ResMed, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Omron Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Invacare Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Linde PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 A&D HOLON Holdings Company, Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.9 Fresenius SE & Co. KGaA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. F. Hoffmann-La Roche Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Companies Mentioned
- Amedisys, Inc.
- LHC Group, Inc.
- ResMed, Inc.
- Omron Corporation
- Abbott Laboratories
- Invacare Corporation
- Linde PLC
- A&D HOLON Holdings Company, Limited
- Fresenius SE & Co. KGaA
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
